Search

everythinglearnresearchcommunity

for

Search:↓

Certain gene variations are linked to a higher risk of severe acne, suggesting a genetic influence on the condition.

Blood AMH levels are higher in women with PCOS than in those with other similar conditions.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

Women with PCOS have lower adiponectin hormone levels and are more likely to have insulin resistance.

Finasteride improves acne and hair loss in women with normal testosterone.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

Women with hirsutism have different levels of omentin-1, which may be linked to the condition and its genetic aspects.

Sleep, testosterone levels, and a specific enzyme activity affect skin oil production in women.

Men and premenopausal women in Korea show different patterns in iron and vitamin D levels, with no clear pattern for postmenopausal women.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Shorter CAG repeats in a specific gene may increase male hormone activity and symptoms like acne and excess hair in women with PCOS.

Ovarian steroid cell tumors should be considered in adults with hirsutism and high testosterone, with surgery as the main treatment.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Insulin resistance and high male hormone levels are major causes of Polycystic Ovary Syndrome.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Most women referred for excess male hormone symptoms had polycystic ovary syndrome (PCOS), with other conditions being less common.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

Hormonal treatments can help with acne, especially in women, by lowering androgen levels or blocking their effects.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Men and women experience skin aging differently due to changes in sex hormone levels with age.

The oral contraceptive ethinylestradiol/chlormadinone acetate is effective in reducing acne and improving other skin conditions related to high androgen levels.

Women with a certain type of tumor had higher levels of pregnancy hormone and male hormones, which decreased after treatment.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.